Impact of corticosteroids in hospitalised COVID-19 patients

Abstract

In patients hospitalised with COVID-19 pneumonia, corticosteroid use within the first 7 days of admission decreased mortality and ICU admissions with no associated increase in bacteraemia or fungaemia.